Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ATTO will rise by +11.36% over the next 2 Weeks and hit $25.09 by Thursday, September 24, 2026. In that time frame, ATTO's share price is expected to range between $23.31 and $26.72.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 24, 2026 | 23.31 | 25.09 | 26.72 |
| Sep 23, 2026 | 23.09 | 24.72 | 26.40 |
| Sep 22, 2026 | 23.14 | 24.78 | 26.46 |
| Sep 21, 2026 | 23.42 | 25.06 | 26.75 |
| Sep 18, 2026 | 22.88 | 24.53 | 26.18 |
| Sep 17, 2026 | 22.35 | 23.98 | 25.72 |
| Sep 16, 2026 | 21.86 | 23.61 | 25.30 |
| Sep 15, 2026 | 22.10 | 23.67 | 25.36 |
| Sep 14, 2026 | 22.23 | 23.95 | 25.54 |
| Sep 11, 2026 | 21.75 | 23.43 | 25.08 |
ATTO shares fell -1.44% in Thursday, September 10, 2026's trading session, dropping from a previous close of $22.86 to move at $22.53. The stock demonstrated notable intraday movement (see ATTO's key stats for a full breakdown), fluctuating between $22.13 and $24.11, a +8.92% trading range. While recent weeks have seen some volatility, ATTO has managed to secure a +4.99% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 190.02K shares changing hands, 4.66K fewer than the previous session. This amounted to $4.28M in total market activity.
Will ATTO Continue Its Upward Trend?
According to analyst ratings and projections for ATTO, Attovia Therapeutics, Inc. shares are anticipated to increase by +15.68%, potentially reaching $26.72 per share by September 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for ATTO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the ATTO stock forecast, now is a good time to buy ATTO stock because its current trading price is -10.20% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ATTO covering social and institutional perspectives.
ATTO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ATTO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.45% to 51.16%) suggest the stock is in a neutral to slightly bearish momentum phase.Insights into ATTO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Attovia Therapeutics Short-Term Forecasts
ATTO Forecast For Next 5 Days
Our algorithm anticipates Attovia Therapeutics (ATTO) stock could hit $25.65 by Sep 17, 2026. This represents a +13.87% fall from today's price, following a - change over the past five days.
ATTO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Attovia Therapeutics, Inc. (ATTO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $23.57, which would mean a +4.62% increase from the current price of $22.53. Projections for this period range from a high of $30.32 to a low of $18.49.
ATTO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Attovia Therapeutics's price over the next three months point to a rise. ATTO stock is expected to peak at $337.16 on Sep 22, 2026 before potentially dipping to $0.00 on Dec 08, 2026. On average, ATTO is likely to trade around $79.69 in the coming 90 days.
Attovia Therapeutics Stock Forecast 2025
Based on our predictive models, Attovia Therapeutics (ATTO) is expected to trade between $0.00 and $337.16 throughout 2026. This would result in an average price of $75.84, potentially offering investors a +236.62% return from current levels.
Attovia Therapeutics, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Attovia Therapeutics, Inc. (ATTO) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $337.16, settling at an average of $162.48. This could translate to a +621.17% gain.
October 2026
Based on current market signals, Attovia Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $162.12, with a likely average price of $58.73. Investors could expect a potential return of +160.67%.
November 2026
Our predictive algorithms indicate Attovia Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$176.00, with an average target of $67.07. This represents a positive outlook and a possible gain of +197.69%.
December 2026
Analyzing established trends, Attovia Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $221.73, averaging around $47.47. This suggests a +110.70% gain from current levels.
January 2027
Market indicators suggest Attovia Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $69.00 to $89.59, with a midpoint forecast of $84.10. The stock might deliver a +273.28% gain.
February 2027
Forecasting for February 2027, models estimate that Attovia Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $14.20 and $400.04, averaging $180.64. This signals a positive trajectory with potential returns around +701.78%.
March 2027
According to our latest forecast models, Attovia Therapeutics, Inc. (ATTO) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $241.75, settling at an average of $97.40. This could translate to a +332.31% gain.
April 2027
Based on current market signals, Attovia Therapeutics, Inc. is projected to trend april 2027. We forecast a trading range from $0.00 to $238.82, with a likely average price of $107.24. Investors could expect a potential return of +375.99%.
May 2027
Our predictive algorithms indicate Attovia Therapeutics, Inc. stock may see a shift in May 2027. The expected range spans $0.00–$291.23, with an average target of $79.51. This represents a positive outlook and a possible gain of +252.91%.
June 2027
Analyzing established trends, Attovia Therapeutics, Inc. looks set to move in June 2027. Projections place the stock between $144.40 and $152.36, averaging around $147.65. This suggests a +555.35% gain from current levels.
July 2027
Market indicators suggest Attovia Therapeutics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $462.85, with a midpoint forecast of $212.87. The stock might deliver a +844.83% gain.
August 2027
Forecasting for August 2027, models estimate that Attovia Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $27.56 and $298.18, averaging $159.10. This signals a positive trajectory with potential returns around +606.17%.
September 2027
According to our latest forecast models, Attovia Therapeutics, Inc. (ATTO) is positioned to show a strong performance in September 2027. The price is predicted to move between $58.33 and $283.11, settling at an average of $198.72. This could translate to a +782.02% gain.
ATTO's history of dividends and stock splits also plays a role in long-term investor confidence.

